author-photo

Riikka Karjalainen

University of Helsinki

35

Papers

645

Citations

Citation Trend

Filter By

Papers (20) Sort By

Journal Conference Others

JAK1/2 and BCL2 inhibitors synergize to counteract bone marrow stromal cell-induced protection of AML

2017 Blood
Show All
- Source
- Cite
- Save
Citations (62)
Identification and Clinical Exploration of Individualized Targeted Therapeutic Approaches in Acute Myeloid Leukemia Patients By Integrating Drug Response and Deep Molecular Profiles

2017 Blood
Show All
- Source
- Cite
- Save
Citations (1)
Elevated Expression of the S100A8/S100A9 Complex in AML Correlates with Reduced Sensitivity to the BCL2 Inhibitor Venetoclax

2017 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Enhanced sensitivity to glucocorticoids in cytarabine-resistant AML.

2017 Leukemia
Show All
- Source
- Cite
- Save
Citations (31)
Targeting of JAK/STAT Signaling to Reverse Stroma-Induced Cytoprotection Against BCL2 Antagonist Venetoclax in Acute Myeloid Leukemia

2016 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Stratification of Multiple Myeloma Patients Based on Ex Vivo Drug Sensitivity and Identification of New Treatments for Patients with High-Risk Relapsed/Refractory Disease

2015 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Quantitative scoring of differential drug sensitivity for individually optimized anticancer therapies

2015 Scientific Reports
Show All
- Source
- Cite
- Save
Citations (173)
Identification of precision treatment strategies for high risk multiple myeloma by ex vivo drug sensitivity testing

2015 Clinical Lymphoma, Myeloma & Leukemia
Show All
- Source
- Cite
- Save
Citations (1)
Identification of Dual PI3K/mTOR and BCL2 Inhibitors for the Treatment of High Risk Multiple Myeloma

2014 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Stroma-Derived Factors Significantly Impact the Drug Response Profiles of Patient-Derived Primary AML Cells: Implications for Drug Sensitivity Testing

2014 Blood
Show All
- Source
- Cite
- Save
Citations (0)